GB1352125A - Antigenic extracts - Google Patents
Antigenic extractsInfo
- Publication number
- GB1352125A GB1352125A GB1352125DA GB1352125A GB 1352125 A GB1352125 A GB 1352125A GB 1352125D A GB1352125D A GB 1352125DA GB 1352125 A GB1352125 A GB 1352125A
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteinaceous
- brucella
- surfactant
- agglutinogenic
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000284 extract Substances 0.000 title abstract 3
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 239000000463 material Substances 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- 241000589562 Brucella Species 0.000 abstract 2
- 241000589567 Brucella abortus Species 0.000 abstract 2
- 239000003945 anionic surfactant Substances 0.000 abstract 2
- 229940056450 brucella abortus Drugs 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000004094 surface-active agent Substances 0.000 abstract 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000004523 agglutinating effect Effects 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 239000004411 aluminium Substances 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 150000003385 sodium Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/098—Brucella
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3445770 | 1970-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1352125A true GB1352125A (en) | 1974-05-08 |
Family
ID=10365885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1352125D Expired GB1352125A (en) | 1970-07-16 | 1970-07-16 | Antigenic extracts |
Country Status (5)
Country | Link |
---|---|
DE (1) | DE2134930A1 (enrdf_load_stackoverflow) |
FR (1) | FR2100920B1 (enrdf_load_stackoverflow) |
GB (1) | GB1352125A (enrdf_load_stackoverflow) |
IE (1) | IE35396B1 (enrdf_load_stackoverflow) |
NL (1) | NL7109451A (enrdf_load_stackoverflow) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993016728A1 (en) * | 1992-02-25 | 1993-09-02 | The Texas A & M University System | Improved vaccin against brucella abortus |
US5718903A (en) * | 1987-03-30 | 1998-02-17 | The Texas A&M University System | Vaccine comprising Brucella abortus which has O polysaccharide antigen absent |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4148877A (en) * | 1975-12-29 | 1979-04-10 | Choay S. A. | Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction |
FR2506615A1 (fr) * | 1981-06-01 | 1982-12-03 | Merieux Inst | Vaccin contre les brucelloses humaines et son procede de fabrication |
FR2524315B1 (fr) * | 1982-04-02 | 1985-07-12 | Merieux Inst | Nouvel antigene pour la recherche de l'hypersensibilite cutanee brucellique notamment chez l'homme, et son procede de preparation |
-
1970
- 1970-07-16 GB GB1352125D patent/GB1352125A/en not_active Expired
-
1971
- 1971-06-24 IE IE81271A patent/IE35396B1/xx unknown
- 1971-07-08 NL NL7109451A patent/NL7109451A/xx unknown
- 1971-07-13 DE DE19712134930 patent/DE2134930A1/de active Pending
- 1971-07-15 FR FR7125920A patent/FR2100920B1/fr not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718903A (en) * | 1987-03-30 | 1998-02-17 | The Texas A&M University System | Vaccine comprising Brucella abortus which has O polysaccharide antigen absent |
WO1993016728A1 (en) * | 1992-02-25 | 1993-09-02 | The Texas A & M University System | Improved vaccin against brucella abortus |
Also Published As
Publication number | Publication date |
---|---|
NL7109451A (enrdf_load_stackoverflow) | 1972-01-18 |
FR2100920A1 (enrdf_load_stackoverflow) | 1972-03-24 |
DE2134930A1 (de) | 1972-01-20 |
FR2100920B1 (enrdf_load_stackoverflow) | 1976-04-16 |
IE35396L (en) | 1972-01-16 |
IE35396B1 (en) | 1976-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Allen et al. | The effect of puromycin on rabbit reticulocyte ribosomes | |
Lawton et al. | Biosynthesis and purification of V and W antigen in Pasteurella pestis | |
GB1439847A (en) | Bacterial extracts | |
KR830002875A (ko) | 모나콜린 k의 제조방법 | |
DE3372018D1 (en) | Preparation for the diagnosis of chlamydial infections and for the production of chlamydial group-specific antibodies | |
GB1352125A (en) | Antigenic extracts | |
GB1292803A (en) | Improvements relating to the production of antigens | |
GB1438556A (en) | Method for preparing non-specific agents for stimulating immunity to tumours and pharmaceutical compositions containing such agent | |
GB1137170A (en) | Method of synthesizing in vitro biologically active intact nucleic acid and new biologically active products and replicases therefor and method of making such replicases | |
Dodgson et al. | Studies on sulphatases. 8. The arylsulphatase of a strain of Alcaligenes metalcaligenes isolated from inter-tidal mud | |
GB1488800A (en) | Influenza vaccines | |
ES379642A1 (es) | Procedimiento para la obtencion de vacunas perfeccionadas. | |
GB1375866A (enrdf_load_stackoverflow) | ||
Andron LA et al. | Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis | |
Calderone et al. | Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain | |
Theron et al. | Virus-like particles in the cells of a primary carcinoma of the liver | |
Horton-Smith et al. | The development of Eimeria necatrix Johnson, 1930 and Eimeria brunetti Levine, 1942 in the caeca of the domestic fowl (Gallus domesticus) | |
GB1449606A (en) | Vaccine preparation | |
GB1109742A (en) | Process for purifying b. pertussis antigen-containing material | |
BR9407141A (pt) | Método para a precipatação de avermectinas naturais | |
GB1293470A (en) | Improved allergenic extract and process for preparing same | |
GB1358321A (en) | Method od tissue cell culture | |
GB980346A (en) | Improvements in or relating to novel antibiotics and the manufacture thereof | |
GB1218278A (en) | Stabilised aluminium hydroxide suspensions | |
GB1267591A (en) | Antigenic materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |